St Andrews Research Repository

St Andrews University Home
View Item 
  •   St Andrews Research Repository
  • University of St Andrews Research
  • University of St Andrews Research
  • University of St Andrews Research
  • View Item
  •   St Andrews Research Repository
  • University of St Andrews Research
  • University of St Andrews Research
  • University of St Andrews Research
  • View Item
  •   St Andrews Research Repository
  • University of St Andrews Research
  • University of St Andrews Research
  • University of St Andrews Research
  • View Item
  • Login
JavaScript is disabled for your browser. Some features of this site may not work without it.

Somatic cancer genetics in the UK : real-world data from phase I of the Cancer Research UK Stratified Medicine Programme

Thumbnail
View/Open
Lindsay_2018_ESMOOpen_Somaticcancer_CC.pdf (963.1Kb)
Date
05/09/2018
Author
Lindsay, Colin R
Shaw, Emily C
Blackhall, Fiona
Blyth, Kevin G
Brenton, James D
Chaturvedi, Anshuman
Clarke, Noel
Dick, Craig
Evans, Thomas R J
Hall, Geoff
Hanby, Andrew M
Harrison, David J
Johnston, Stephen R D
Mason, Malcolm D
Morton, Dion
Newton-Bishop, Julia
Nicholson, Andrew G
Oien, Karin A
Popat, Sanjay
Rassl, Doris
Sharpe, Rowena
Taniere, Phillipe
Walker, Ian
Wallace, William A
West, Nicholas P
Butler, Rachel
Gonzalez de Castro, David
Griffiths, Mike
Johnson, Peter W M
Keywords
RC0254 Neoplasms. Tumors. Oncology (including Cancer)
NDAS
Metadata
Show full item record
Altmetrics Handle Statistics
Altmetrics DOI Statistics
Abstract
Introduction: Phase I of the Cancer Research UK Stratified Medicine Programme (SMP1) was designed to roll out molecular pathology testing nationwide at the point of cancer diagnosis, as well as facilitate an infrastructure where surplus cancer tissue could be used for research. It offered a non-trial setting to examine common UK cancer genetics in a real-world context. Methods: A total of 26 sites in England, Wales and Scotland, recruited samples from 7814 patients for genetic examination between 2011 and 2013. Tumour types involved were breast, colorectal, lung, prostate, ovarian cancer and malignant melanoma. Centralised molecular testing of surplus material from resections or biopsies of primary/metastatic tissue was performed, with samples examined for 3-5 genetic alterations deemed to be of key interest in site-specific cancers by the National Cancer Research Institute Clinical Study groups. Results: 10 754 patients (98% of those approached) consented to participate, from which 7814 tumour samples were genetically analysed. In total, 53% had at least one genetic aberration detected. From 1885 patients with lung cancer, KRAS mutation was noted to be highly prevalent in adenocarcinoma (37%). In breast cancer (1873 patients), there was a striking contrast in TP53 mutation incidence between patients with ductal cancer (27.3%) and lobular cancer (3.4%). Vast inter-tumour heterogeneity of colorectal cancer (1550 patients) was observed, including myriad double and triple combinations of genetic aberrations. Significant losses of important clinical information included smoking status in lung cancer and loss of distinction between low-grade and high-grade serous ovarian cancers. Conclusion: Nationwide molecular pathology testing in a non-trial setting is feasible. The experience with SMP1 has been used to inform ongoing CRUK flagship programmes such as the CRUK National Lung MATRIX trial and TRACERx.
Citation
Lindsay , C R , Shaw , E C , Blackhall , F , Blyth , K G , Brenton , J D , Chaturvedi , A , Clarke , N , Dick , C , Evans , T R J , Hall , G , Hanby , A M , Harrison , D J , Johnston , S R D , Mason , M D , Morton , D , Newton-Bishop , J , Nicholson , A G , Oien , K A , Popat , S , Rassl , D , Sharpe , R , Taniere , P , Walker , I , Wallace , W A , West , N P , Butler , R , Gonzalez de Castro , D , Griffiths , M & Johnson , P W M 2018 , ' Somatic cancer genetics in the UK : real-world data from phase I of the Cancer Research UK Stratified Medicine Programme ' , ESMO Open , vol. 3 , no. 6 , e000408 . https://doi.org/10.1136/esmoopen-2018-000408
Publication
ESMO Open
Status
Peer reviewed
DOI
https://doi.org/10.1136/esmoopen-2018-000408
ISSN
2059-7029
Type
Journal article
Rights
Copyright © Author(s) 2018. Open Access article. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ on behalf of the European Society for Medical Oncology. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, any changes made are indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
Description
This study was supported by Cancer Research UK, AstraZeneca and Pfizer UK.
Collections
  • Medicine Research
  • University of St Andrews Research
URI
http://hdl.handle.net/10023/16134

Items in the St Andrews Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.

Advanced Search

Browse

All of RepositoryCommunities & CollectionsBy Issue DateNamesTitlesSubjectsClassificationTypeFunderThis CollectionBy Issue DateNamesTitlesSubjectsClassificationTypeFunder

My Account

Login

Open Access

To find out how you can benefit from open access to research, see our library web pages and Open Access blog. For open access help contact: openaccess@st-andrews.ac.uk.

Accessibility

Read our Accessibility statement.

How to submit research papers

The full text of research papers can be submitted to the repository via Pure, the University's research information system. For help see our guide: How to deposit in Pure.

Electronic thesis deposit

Help with deposit.

Repository help

For repository help contact: Digital-Repository@st-andrews.ac.uk.

Give Feedback

Cookie policy

This site may use cookies. Please see Terms and Conditions.

Usage statistics

COUNTER-compliant statistics on downloads from the repository are available from the IRUS-UK Service. Contact us for information.

© University of St Andrews Library

University of St Andrews is a charity registered in Scotland, No SC013532.

  • Facebook
  • Twitter